Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Y 90 monoclonal antibody M195

A radioimmunoconjugate of humanized M195 monoclonal antibody (MoAb) conjugated with isotope yttrium 90. MoAb M195 is reactive with the cell surface antigen CD33, a glycoprotein found on myeloid leukemia blasts and early hematopoietic progenitor cells but not on normal stem cells. This radioimmunoconjugate emits beta particles that causes cytotoxicity in tumor cells and has both imaging and therapeutic uses.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	MOAB M195, yttrium Y 90 monoclonal antibody M195, yttrium Y 90 yttrium Y 90 monoclonal antibody M195
Abbreviation:	Y 90 MoAb M195

Y 90 monoclonal antibody M195

Search NCI's Drug Dictionary